2009-11-10 19:17:03 -
Cardium Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/cardium-ther ..
Cardium Therapeutics, Inc. (Cardium) is medical technology company that develops and commercializes biologic therapeutics and medical devices for cardiovascular and ischemic disease. Cardium assembled its portfolio of cardiovascular and regenerative medicine with the acquisition of three companies since October 2005. Its lead product candidate, Generx is a DNA based growth factor therapeutic for use by interventional cardiologists to stimulate the
growth of collateral circulation in heart of patients with ischemic conditions. The company markets its products through our direct sales force. The company has two subsidiaries namely, Innercool Therapies, Inc. and Tissue Repair Company.
The Cardium Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
